myamgen.amgen.com

myamgen.amgen.com Profile

myamgen.amgen.com

Maindomain:amgen.com

Title:

Description:About Back About Overview The Difference Quick Facts Mission and Values Leadership How We Operate Back How We Operate Overview Corporate Governance Business Ethics and Compliance Policies, Practices a

Discover myamgen.amgen.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

myamgen.amgen.com Information

Website / Domain: myamgen.amgen.com
HomePage size:175.834 KB
Page Load Time:0.269595 Seconds
Website IP Address: 52.36.218.138
Isp Server: E.I. du Pont de Nemours and Co. Inc.

myamgen.amgen.com Ip Information

Ip Country: United States
City Name: Wilmington
Latitude: 39.749801635742
Longitude: -75.554298400879

myamgen.amgen.com Keywords accounting

Keyword Count

myamgen.amgen.com Httpheader

Date: Thu, 23 Jan 2020 08:29:48 GMT
Content-Type: text/html; charset=utf-8
Content-Length: 40800
Connection: keep-alive
Set-Cookie: AWSALB=0eb+CLhls6EMOMISwDcMiAZP8g+vh6c3bsGVJilJfzlTsVogzFAGkNTCmQHeAEinM23FO5f8IIfGi3h4tZtjffhA6ADhVBHGb0mq0vkkGLZIWLpB2KsboKd2D4Ks; Expires=Thu, 30 Jan 2020 08:29:48 GMT; Path=/, www-amgen-com#lang=en; path=/, ASP.NET_SessionId=l5fgrhamnpzs3c4k33t5ol32; path=/; HttpOnly
Cache-Control: no-cache, no-store
Pragma: no-cache
Content-Encoding: gzip
Expires: -1
Vary: Accept-Encoding
X-UA-Compatible: IE=edge
Content-Security-Policy: "frame-ancestors self http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com", X-Frame-Options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com
X-Xss-Protection: 1; mode=block

myamgen.amgen.com Meta Info

content="D4ftAcAo528vk
3NGkFiqh_jJlvdPuvPgzdlpelBKY" name="google-site-verification"/
charset="utf-8"/
content="width=device-width, initial-scale=1.0" name="viewport"/
content="Amgen" property="og:title"/
content="" property="og:description"/
content="" property="og:image"/
content="http://www.amgen.com/en" property="og:url"/
content="summary_large_image" name="twitter:card"/
content="Amgen, Inc" property="og:site_name"/
content="Amgen" name="twitter:image:alt"/
content="@amgen" name="twitter:site"/
content="JizhPYsK12IEBBfMPT_WOVO7qHCUp_p-3nw02Odg-0o" name="google-site-verification"
name="have-i-been-pwned-verification" value="c5f3c523bf0e18b94af943da47a79d11"/
content="IE=edge" http-equiv="X-UA-Compatible"

52.36.218.138 Domains

Domain WebSite Title

myamgen.amgen.com Similar Website

Domain WebSite Title

myamgen.amgen.com Traffic Sources Chart

myamgen.amgen.com Alexa Rank History Chart

myamgen.amgen.com aleax

myamgen.amgen.com Html To Plain Text

About Back About Overview The Difference Quick Facts Mission and Values Leadership How We Operate Back How We Operate Overview Corporate Governance Business Ethics and Compliance Policies, Practices and Disclosures Awards and Accolades History Science Back Science Overview Research and Development Strategy Pipeline Scientific Advisory Boards Science Clinical Trials Back Clinical Trials Overview About Clinical Trials Clinical Trials Information for Healthcare Professionals Clinical Trial Transparency, Data Sharing and Disclosure Practices Clinical Out-of-Hours Support Program Investigator Sponsored Studies Manufacturing Biosimilars products Back products Overview Medical Information Global Patient Safety Back Global Patient Safety Overview Adverse Event and Product Complaint Reporting Counterfeit Drug Statement Safety Data Sheets Responsibility Back Responsibility Overview ’s Commitment to Patients 2018 Responsibility Highlights Report Foundation Back Foundation Overview Programs for Students Programs for Teachers About the Foundation Staff Engagement Our Approach to Pricing, Access and Affordability Access to Medicine Back Access to Medicine Overview Reimbursement Support Services and Financial Assistance Programs Access to Medicines Initiatives Outside the U.S. The Value of Our Medicines Access to Investigational Medicines Diversity and Inclusion Environment Supplier Sustainability Grants and Giving Back Grants and Giving Overview Foundation Grants Independent Medical Education Funding U.S. Healthcare Donations Non-Healthcare Donations and Sponsorships Equipment Donations Donation and Grant Recipient List Safety and Wellness Back Safety and Wellness Overview Safety Wellness Reporting and Metrics Contact Us Back Contact Us Locations Product Inquiries Investors Media Partners Careers Worldwide Back Worldwide Australia - English Austria - Deutsch Belgium - Français Belgium - Nederlands Brazil - Português Bulgaria - български Canada - English Canada - Français China - English China - 汉语 Croatia - Hrvatski Czech Republic - český Denmark - Dansk Finland - Suomen Kieli France - Français Germany - Deutsch Greece - ελληνικά Hong Kong - 中文 Hong Kong - English Hungary - Magyarország Ireland - English Italy - Italiano Japan - English Japan - 日本語 Korea - English Korea - 한국어 Mexico - Español Netherlands - English Netherlands - Nederlands Norway - Norsk Poland - język polski Portugal - Português Romania - Limba Română Russia - русский язык Singapore - English Slovakia - Slovenčina Slovenia - Slovenščina Spain - Español Sweden - Svenska Switzerland - Français Switzerland - Deutsch Taiwan - English Taiwan - 中文 Thailand - English Thailand - ไทย Turkey - Türkçe United Kingdom - English United States - English Web Resources Back Web Resources Science Resources Pipeline Science Biotechnology by Introduction to Biotechnology Disease Education Breakaway from Heart Disease ™ Breakaway from Cancer ® Preventing Infections in Cancer Patients Areas of Focus Biosimilars Business Development Foundation Oncology Search Worldwide Web Resources Investors Media Partners Careers Worldwide A biotechnology pioneer since 1980, has reached millions of patients around the world. Australia English Austria Deutsch Belgium Français | Nederlands Brazil Português Bulgaria български Canada English | Français China English | 汉语 Croatia Hrvatski Czech Republic český Denmark Dansk Finland Suomen Kieli France Français Germany Deutsch Greece ελληνικά Hong Kong 中文 | English Hungary Magyarország Ireland English Italy Italiano Japan English | 日本語 Korea English | 한국어 Mexico Español Netherlands English | Nederlands Norway Norsk Poland język polski Portugal Português Romania Limba Română Russia русский язык Singapore English Slovakia Slovenčina Slovenia Slovenščina Spain Español Sweden Svenska Switzerland Français | Deutsch Taiwan English | 中文 Thailand English | ไทย Turkey Türkçe United Kingdom English United States English Web Resources has developed a collection of online resources available to help you learn more about areas of interest. Science Resources Pipeline Science Biotechnology by Introduction to Biotechnology Disease Education Breakaway from Heart Disease ™ Breakaway from Cancer ® Preventing Infections in Cancer Patients Areas of Focus Biosimilars Business Development Foundation Oncology About Overview The Difference Quick Facts Mission and Values Leadership How We Operate Awards and Accolades History Science Overview Research and Development Strategy Pipeline Scientific Advisory Boards Science Clinical Trials Manufacturing Biosimilars products Overview Medical Information Global Patient Safety Counterfeit Drug Statement Safety Data Sheets Responsibility Overview ’s Commitment to Patients 2018 Responsibility Highlights Report Foundation Our Approach to Pricing, Access and Affordability Access to Medicine Diversity and Inclusion Environment Supplier Sustainability Grants and Giving Safety and Wellness Reporting and Metrics × Do you want to link to this External Site and leave .com? No, Return to .com Yes, Leave .com YOU ARE NOW LEAVING AMGEN'S WEB SITE. takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. × Do you want to link to this External Site and leave .com? No, Return to .com. Yes, Leave .com YOU ARE NOW LEAVING AMGEN'S WEB SITE. takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. × Do you want to link to this External Site and leave .com? No, Return to .com Yes, Leave .com YOU ARE NOW LEAVING AMGEN'S WEB SITE. takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. × Do you want to link to this External Site and leave .com? No, Return to .com Yes, Leave .com YOU ARE NOW LEAVING AMGEN'S WEB SITE. takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. × Free “LabXchange” Science Education Accelerator Launched by Foundation and Harvard’s Faculty of Arts and Sciences LabXchange by Foundation and Harvard’s Faculty of Arts and Sciences Reimagines the Science Experience for Students Around the Globe Read Press Release Science Education Needs a Reboot. LabXchange Can Help. Foundation president Eduardo Cetlin explains how in an op-ed for STAT. Get a Behind-the-Scenes Look at How and Why LabXchange Was Created A Q&A with Dr. Robert Lue, the researcher who led development of the innovative laboratory platform. Message of Equality Shared with Family, Friends and Community on Martin Luther King, Jr. Day Announces Global Diagnostic Collaborations to Expand Molecular Testing for Patients with Non-Small Cell Lung Cancer Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China Strategic Collaboration Will Accelerate ’s Expansion in China Celebrates Pioneering Scientist Chris Paszty The accomplished gene hunter spent two decades leading the research for what ultimately became an innovative therapy for osteoporosis. Three Ways Biotech Is Changing How We Treat Cancer Meet Alper Ureten, ’s New GM of the Biosimilars Business Unit Hosts Social Media Influencer Summit to Shine a Light on Osteoporosis Landmark deCODE Study Sheds New Light on Role of Lp(a) in Heart Disease The large-scale genomics study has helped to disentangle the attributes of Lp(a) that drive cardiovascular risk. Employees Prepare and Deliver Care Packages to Homeless in Downtown Los Angeles What Are Your Preferred Pronouns? 3 takeaways from ’s transgender and gender diversity panel. More Featured Stories Recent News More News ’s Dedication to Heart Disease is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s he...

myamgen.amgen.com Whois

"domain_name": [ "AMGEN.COM", "amgen.com" ], "registrar": "MarkMonitor, Inc.", "whois_server": "whois.markmonitor.com", "referral_url": null, "updated_date": [ "2015-09-17 19:40:14", "2018-02-06 15:41:40-08:00" ], "creation_date": [ "1990-07-27 04:00:00", "1990-07-27 00:00:00-07:00" ], "expiration_date": [ "2023-07-26 04:00:00", "2023-07-25 21:00:00-07:00" ], "name_servers": [ "NS1.AMGEN.COM", "NS2.AMGEN.COM", "NS3.AMGEN.COM", "ns1.amgen.com", "ns3.amgen.com", "ns2.amgen.com" ], "status": [ "clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited", "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited", "serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited", "serverTransferProhibited https://icann.org/epp#serverTransferProhibited", "serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited", "clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)", "clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)", "clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)", "serverUpdateProhibited (https://www.icann.org/epp#serverUpdateProhibited)", "serverTransferProhibited (https://www.icann.org/epp#serverTransferProhibited)", "serverDeleteProhibited (https://www.icann.org/epp#serverDeleteProhibited)" ], "emails": [ "abusecomplaints@markmonitor.com", "amgendomains@amgen.com", "whoisrequest@markmonitor.com" ], "dnssec": "unsigned", "name": "Patent Law Group", "org": "Amgen, Inc.", "address": "1 Amgen Center Drive, MS 28-2-C", "city": "Thousand Oaks", "state": "CA", "zipcode": "91320", "country": "US"